Wednesday, November 4, 2026||
MultiKhabarMultiKhabar

Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth

Share:WhatsAppFacebookX (Twitter)Telegram
Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth
Photo / Coverage: The Hindu Business Line
EXECUTIVE SUMMARY

The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue

Key Takeaways

  • Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth.

The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Hindu Business Line

Visit Publisher Site →

Related News

🇮🇳 India
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play